Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Thrombo-Inflammation in Cardiovascular Disease: An Expert Consensus Document from the Third Maastricht Consensus Conference on Thrombosis
Elisa D’Alessandro, Christian Becker, Wolfgang Bergmeier, et al.
Thrombosis and Haemostasis (2020) Vol. 120, Iss. 04, pp. 538-564
Open Access | Times Cited: 81

Showing 26-50 of 81 citing articles:

Activation of coagulation FXI promotes endothelial inflammation and amplifies platelet activation in a nonhuman primate model of hyperlipidemia
Tia C. L. Kohs, Helen H. Vu, Kelley R. Jordan, et al.
Research and Practice in Thrombosis and Haemostasis (2023) Vol. 8, Iss. 1, pp. 102276-102276
Open Access | Times Cited: 9
NETosis in ischemic/reperfusion injuries: An organ-based review
Payam Hashemi, Masoud Nouri‐Vaskeh, Leila Alizadeh, et al.
Life Sciences (2021) Vol. 290, pp. 120158-120158
Closed Access | Times Cited: 18
The innate immune response, microenvironment proteinases, and the COVID-19 pandemic: pathophysiologic mechanisms and emerging therapeutic targets
Morley D. Hollenberg, Murray Epstein
Kidney International Supplements (2022) Vol. 12, Iss. 1, pp. 48-62
Open Access | Times Cited: 14
Pleiotropic Effects of the Protease-Activated Receptor 1 (PAR1) Inhibitor, Vorapaxar, on Atherosclerosis and Vascular Inflammation
Julian Friebel, Eileen Moritz, Marco Witkowski, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3517-3517
Open Access | Times Cited: 17
Anxiety and depression are associated with heightened risk of incident deep vein thrombosis: Mediation through stress‐related neural mechanisms
Rachel Rosovsky, Kenechukwu Mezue, Charbel Gharios, et al.
American Journal of Hematology (2024) Vol. 99, Iss. 10, pp. 1927-1938
Closed Access | Times Cited: 2
Endothelial dysfunction and vascular maladaptation in atrial fibrillation
Shuguang Qin, Maxime Boidin, Benjamin J. R. Buckley, et al.
European Journal of Clinical Investigation (2021) Vol. 51, Iss. 5
Open Access | Times Cited: 15
Associations of NETs with inflammatory risk and atherosclerotic severity in ST-segment elevation myocardial infarction
Jinying Zhou, Runzhen Chen, Chen Liu, et al.
Thrombosis Research (2021) Vol. 203, pp. 5-11
Closed Access | Times Cited: 15
Atypical Roles of the Chemokine Receptor ACKR3/CXCR7 in Platelet Pathophysiology
Madhumita Chatterjee
Cells (2022) Vol. 11, Iss. 2, pp. 213-213
Open Access | Times Cited: 11
The mechanistic basis linking cytokine storm to thrombosis in COVID-19
Adam J. Wolf, Farhad Khimani, Braian Yoon, et al.
Thrombosis Update (2022) Vol. 8, pp. 100110-100110
Open Access | Times Cited: 10
Cytotoxic CD8+ T Cells Are Involved in the Thrombo-Inflammatory Response during First-Diagnosed Atrial Fibrillation
Julian Friebel, Marco Witkowski, Max Wegner, et al.
Cells (2022) Vol. 12, Iss. 1, pp. 141-141
Open Access | Times Cited: 10
What do we know about platelets in myocardial ischemia-reperfusion injury and why is it important?
Lun Wang, Yifan Liu, Ran Tian, et al.
Thrombosis Research (2023) Vol. 229, pp. 114-126
Closed Access | Times Cited: 6
Differences in thrombin and plasmin generation potential between East African and Western European adults: The role of genetic and non‐genetic factors
Godfrey S. Temba, Nadira Vadaq, Jun Wan, et al.
Journal of Thrombosis and Haemostasis (2022) Vol. 20, Iss. 5, pp. 1089-1105
Open Access | Times Cited: 9
miR-146a in Cardiovascular Diseases and Sepsis: An Additional Burden in the Inflammatory Balance?
Ana B. Arroyo, Sonia Águila, María Piedad Fernández-Pérez, et al.
Thrombosis and Haemostasis (2020) Vol. 121, Iss. 09, pp. 1138-1150
Open Access | Times Cited: 14
Platelets and coagulation factors: Established and novel roles in atherosclerosis and atherothrombosis
Rory R. Koenen, Christoph J. Binder
Atherosclerosis (2020) Vol. 307, pp. 78-79
Open Access | Times Cited: 13
The role of von Willebrand factor in hemostasis pathology
Yuliya Avtaeva, Ivan Melnikov, S. A. Vasiliev, et al.
Aterotromboz = Atherothrombosis (2023) Vol. 12, Iss. 2, pp. 79-102
Open Access | Times Cited: 4
Thrombotic, Vascular, and Bleeding Complications of the Myeloproliferative Neoplasms
Andrew I. Schafer
Hematology/Oncology Clinics of North America (2021) Vol. 35, Iss. 2, pp. 305-324
Closed Access | Times Cited: 10
Characterization of Biomarkers of Thrombo-Inflammation in Patients with First-Diagnosed Atrial Fibrillation
Julian Friebel, Max Wegner, Leon Blöbaum, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4109-4109
Open Access | Times Cited: 1
Apelin-13 as a novel diagnostic laboratory biomarker in thromboembolic disorders: a review of literature with prospective insights
Mehdi Karimi, Niyousha Shirsalimi, Eshagh Sedighi
International Journal of Emergency Medicine (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 1
An attempt to chemically state the cross-talk between monomers of COX homodimers by double/hybrid inhibitors mofezolac-spacer-mofezolac and mofezolac-spacer-arachidonic acid
Maria Grazia Perrone, Morena Miciaccia, Paola Vitale, et al.
European Journal of Medicinal Chemistry (2020) Vol. 209, pp. 112919-112919
Closed Access | Times Cited: 10
Thrombosis in myeloproliferative neoplasms: update in pathophysiology
Brandi Reeves, Alison R. Moliterno
Current Opinion in Hematology (2021) Vol. 28, Iss. 5, pp. 285-291
Closed Access | Times Cited: 8
Determining ‘thrombogenicity’ in patients with coronary artery disease: what’s next?
Aaron F.J. Iding, Arina J. ten Cate‐Hoek, Hugo Ten Cate
European Heart Journal (2023) Vol. 44, Iss. 19, pp. 1729-1731
Closed Access | Times Cited: 3
AN EVIDENCE BASED ASSESSMENT OF MOST COMMON RISK FACTORS OF MYOCARDIAL INFARCTION: ANALYSIS FROM A LOCAL POPULATION
MM Hafeez, Turker Yasin, Usman Safdar, et al.
Biological and Clinical Sciences Research Journal (2020) Vol. 2020, Iss. 1
Open Access | Times Cited: 8
Targeting Cell-Specific Molecular Mechanisms of Innate Immunity in Atherosclerosis
Manuela Sauter, Harald F. Langer
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 5
Distinct systemic cytokine networks in symptomatic and asymptomatic carotid stenosis
Ricarda Stauß, Gerrit M. Große, Lavinia Neubert, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Short-Term Effects of Supplemental L-Arginine, Diosmin, Troxerutin, and Hesperidin in Diabetic Patients: A Pilot Study
Marco Bagnati, Chiara Puricelli, Giulia Bauce, et al.
BioMed Research International (2021) Vol. 2021, pp. 1-11
Open Access | Times Cited: 6

Scroll to top